Related Experiment Videos

[Therapeutic approaches in gastroesophageal reflux disease]

A Rühl¹, J F Erckenbrecht

¹Abteilung für Gastroenterologie, Heinrich-Heine-Universität, Düsseldorf.

Zeitschrift Fur Gastroenterologie

|April 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease.

Neurogastroenterology and motility·2017

[Chronic motility disorders of the upper gastrointestinal tract in the elderly. Pharmaceutical, endoscopic and operative therapy].

Der Internist·2014

[How safe is sedation in gastrointestinal endoscopy? A multicentre analysis of 388,404 endoscopies and analysis of data from prospective registries of complications managed by members of the Working Group of Leading Hospital Gastroenterologists (ALGK)].

Zeitschrift fur Gastroenterologie·2013

Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome.

Alimentary pharmacology & therapeutics·2011

OTC laxative use of sodium picosulfate â results of a pharmacy-based patient survey (cohort study).

International journal of clinical pharmacology and therapeutics·2008

Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2006

See all related articles